UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Peptides (New York, N.Y. : 1980), ISSN 0196-9781, 02/2018, Volume 100, pp. 173 - 181
GIP receptor antagonist | GIP receptor | Obesity therapy | Glucose-dependent insulinotropic polypeptide (GIP) | Type 2 diabetes therapy | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Gastric Inhibitory Polypeptide - metabolism | Humans | Hypoglycemic Agents - chemistry | Diabetes Mellitus, Type 2 - metabolism | Receptors, Gastrointestinal Hormone - therapeutic use | Receptors, Gastrointestinal Hormone - antagonists & inhibitors | Blood Glucose - drug effects | Adipose Tissue - metabolism | Insulin - metabolism | Receptors, Gastrointestinal Hormone - genetics | Glucose - metabolism | Glucagon - metabolism | Diabetes Mellitus, Type 2 - pathology | Diabetes Mellitus, Type 2 - drug therapy | Adipose Tissue - drug effects | Weight reducing preparations | Type 2 diabetes | Medical research | Peptides | Physiological aspects | Medicine, Experimental | Lipoprotein lipase | Hypoglycemic agents | Glucose | Glucose tolerance tests | Dextrose | Membrane proteins | Index Medicus
Journal Article
British journal of pharmacology, ISSN 0007-1188, 06/2013, Volume 169, Issue 4, pp. 808 - 819
monoacylglycerol lipase | endocannabinoid | NF‐κB | TNF‐α | 2‐AG | brain | JZL184 | IL‐6 | IL‐1β | frontal cortex | IL‐10 | cytokines | plasma | IL-1β | IL-10 | IL-6 | NF-κB | TNF-α | 2-AG | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Benzodioxoles - antagonists & inhibitors | Spleen - immunology | Frontal Lobe - metabolism | Male | Spleen - drug effects | Prostaglandins - blood | Lipopolysaccharides | Monoacylglycerol Lipases - metabolism | Arachidonic Acids - metabolism | Glycerides - blood | Arachidonic Acids - blood | Enzyme Inhibitors - chemistry | Anti-Anxiety Agents - therapeutic use | Benzodioxoles - therapeutic use | Peritonitis - metabolism | Rats | Encephalitis - immunology | Random Allocation | Glycerides - metabolism | Enzyme Inhibitors - therapeutic use | Rats, Sprague-Dawley | Cannabinoid Receptor Antagonists - therapeutic use | Monoacylglycerol Lipases - blood | Peritonitis - drug therapy | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Endocannabinoids - metabolism | Nerve Tissue Proteins - blood | Monoacylglycerol Lipases - antagonists & inhibitors | Piperidines - antagonists & inhibitors | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Anti-Inflammatory Agents, Non-Steroidal - antagonists & inhibitors | Encephalitis - drug therapy | Encephalitis - metabolism | Cytokines - blood | Nerve Tissue Proteins - antagonists & inhibitors | Cytokines - metabolism | Peritonitis - immunology | Nerve Tissue Proteins - metabolism | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Spleen - metabolism | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Piperidines - therapeutic use | Frontal Lobe - drug effects | Cannabinoid Receptor Antagonists - chemistry | Frontal Lobe - immunology | Cytokines - antagonists & inhibitors | Endocannabinoids - blood | Prostaglandins - metabolism | Glycerin | Brain | Unsaturated fatty acids | Cytokines | Glycerol | Lipase | Mitogens | Plasma | Rodents | Index Medicus | Cannabinoids 2012, Part Two | Themed Section
Journal Article
Lipids in health and disease, ISSN 1476-511X, 09/2017, Volume 16, Issue 1, pp. 181 - 181
Obesity | Adipocyte differentiation | Stearidonic acid | 3T3-L1 | Omega-3 fatty acids | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Nutrition & Dietetics | Science & Technology | Fatty Acid Synthase, Type I - genetics | Lipoprotein Lipase - antagonists & inhibitors | Fatty Acid-Binding Proteins - antagonists & inhibitors | Glucose Transporter Type 4 - metabolism | Phosphoenolpyruvate Carboxykinase (ATP) - antagonists & inhibitors | Adipocytes - cytology | Adipocytes - drug effects | Fatty Acid-Binding Proteins - metabolism | PPAR gamma - metabolism | Fatty Acids, Omega-3 - pharmacology | CCAAT-Enhancer-Binding Proteins - antagonists & inhibitors | CCAAT-Enhancer-Binding Proteins - genetics | Lipoprotein Lipase - metabolism | Sterol Regulatory Element Binding Protein 1 - metabolism | PPAR gamma - genetics | CCAAT-Enhancer-Binding Proteins - metabolism | Glucose Transporter Type 4 - antagonists & inhibitors | Cell Survival - drug effects | Glucose Transporter Type 4 - genetics | Lipoprotein Lipase - genetics | CCAAT-Enhancer-Binding Protein-beta - genetics | Stearoyl-CoA Desaturase - antagonists & inhibitors | 3T3-L1 Cells | Fatty Acid Synthase, Type I - metabolism | Fatty Acid-Binding Proteins - genetics | Stearoyl-CoA Desaturase - genetics | CCAAT-Enhancer-Binding Protein-beta - metabolism | Fatty Acid Synthase, Type I - antagonists & inhibitors | Gene Expression Regulation - drug effects | Phosphoenolpyruvate Carboxykinase (ATP) - genetics | Animals | PPAR gamma - antagonists & inhibitors | Sterol Regulatory Element Binding Protein 1 - genetics | Cell Differentiation - drug effects | Adipocytes - metabolism | Phosphoenolpyruvate Carboxykinase (ATP) - metabolism | Lipid Metabolism - drug effects | Sterol Regulatory Element Binding Protein 1 - antagonists & inhibitors | Stearoyl-CoA Desaturase - metabolism | Mice | CCAAT-Enhancer-Binding Protein-beta - antagonists & inhibitors | Usage | Care and treatment | Analysis | Development and progression | Liquid chromatography | Glucose transporter | Vegetable oils | Soybeans | Transcription factors | Fish oils | Toxicity | Gene regulation | Preadipocytes | Mass spectroscopy | Stearoyl-CoA desaturase | Lipoprotein lipase | Adipocytes | Lipase | Desaturase | Gene expression | Fatty acids | Fatty-acid synthase | Polymerase chain reaction | Rodents | Down-regulation | Sterol regulatory element-binding protein | Index Medicus
Journal Article
Science translational medicine, ISSN 1946-6234, 01/2020, Volume 12, Issue 528, p. eaaw7905
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Lipoproteins (low density) | Peptides | Transgenic mice | Molecular dynamics | Triglycerides | Lipoprotein lipase | Bioavailability | Lipase | Drug development | Cholesterol | Lipoproteins | Apolipoprotein C-III | Hypertriglyceridemia | Lipoprotein (low density) receptors | Cardiovascular diseases | Lipoproteins (high density) | Index Medicus
Journal Article
Scientific reports, ISSN 2045-2322, 02/2016, Volume 6, Issue 1, pp. 21931 - 21931
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | RNA, Small Interfering - genetics | Lipoprotein Lipase - antagonists & inhibitors | Seizures - genetics | Humans | Interleukin 1 Receptor Antagonist Protein - genetics | Seizures - metabolism | Interleukin-1beta - genetics | Seizures, Febrile - pathology | Seizures - physiopathology | Seizures, Febrile - physiopathology | Seizures - pathology | Aging - genetics | Piperidines - pharmacology | Interleukin-1beta - metabolism | Interleukin 1 Receptor Antagonist Protein - metabolism | Seizures, Febrile - genetics | Cannabinoid Receptor Antagonists - pharmacology | Lipoprotein Lipase - metabolism | Interleukin-1beta - antagonists & inhibitors | Pyrazoles - pharmacology | Seizures, Febrile - metabolism | Signal Transduction | Lipoprotein Lipase - genetics | Tissue Culture Techniques | Gene Expression Regulation | Morpholines - pharmacology | Hippocampus - pathology | Cyclohexanones - pharmacology | Rats, Sprague-Dawley | Mice, Knockout | Naphthalenes - pharmacology | Hippocampus - metabolism | Receptor, Cannabinoid, CB1 - metabolism | Animals | Receptor, Cannabinoid, CB1 - genetics | Interleukin 1 Receptor Antagonist Protein - antagonists & inhibitors | Benzoxazines - pharmacology | Mice | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | RNA, Small Interfering - metabolism | Index Medicus
Journal Article
Enzyme and microbial technology, ISSN 0141-0229, 04/2015, Volume 71, pp. 53 - 57
Octyl-agarose | Interfacial activation | Detergents | Ionic strength | Irreversible inhibition | Lipase immobilization | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Fungal Proteins - chemistry | Bacterial Proteins - antagonists & inhibitors | Enzymes, Immobilized - chemistry | Enzymes, Immobilized - metabolism | Sepharose - analogs & derivatives | Bacterial Proteins - chemistry | Ascomycota - enzymology | Fungal Proteins - antagonists & inhibitors | Lipase - metabolism | Lipase - chemistry | Osmolar Concentration | Lipase - antagonists & inhibitors | Hydrophobic and Hydrophilic Interactions | Bacterial Proteins - metabolism | Burkholderia cepacia - enzymology | Enzymes, Immobilized - antagonists & inhibitors | Protein Conformation | Kinetics | Cyanogen Bromide | Fungal Proteins - metabolism | Lipase | Catalysis | Index Medicus
Journal Article
Frontiers in endocrinology (Lausanne), ISSN 1664-2392, 2019, Volume 10, pp. 492 - 492
GIP receptor antagonist | GIP receptor | Glucagon-like peptide-2 (GLP-2) | Lipid homeostasis | Glucose-dependent insulinotropic polypeptide (GIP) | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Physiological aspects | Body weight | Lipoprotein lipase | lipid homeostasis | glucagon-like peptide-2 (GLP-2) | glucose-dependent insulinotropic polypeptide (GIP)
Journal Article